1. Chronic Pelvic Ischemia: Contribution to the Pathogenesis of Lower Urinary Tract Symptoms (LUTS): A New Target for Pharmacological Treatment?. Issue 1 (25th November 2014) Authors: ANDERSSON, Karl‐Erik; NOMIYA, Masanori; YAMAGUCHI, Osamu Journal: LUTS Issue: Volume 7:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Guideline for Female Lower Urinary Tract Symptoms. Issue 1 (20th October 2015) Authors: TAKAHASHI, Satoru; TAKEI, Mineo; NISHIZAWA, Osamu; YAMAGUCHI, Osamu; KATO, Kumiko; GOTOH, Momokazu; YOSHIMURA, Yasukuni; TAKEYAMA, Masami; OZAWA, Hideo; SHIMADA, Makoto; YAMANISHI, Tomonori; YOSHIDA, Masaki; TOMOE, Hikaru; YOKOYAMA, Osamu; KOYAMA, Masayasu Journal: LUTS Issue: Volume 8:Issue 1(2016) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Detrusor Underactivity: The Current Concept of the Pathophysiology. Issue 3 (14th August 2014) Authors: YOSHIDA, Masaki; YAMAGUCHI, Osamu Journal: LUTS Issue: Volume 6:Issue 3(2014) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study. Issue 2 (11th March 2014) Authors: YAMAGUCHI, Osamu; MARUI, Eiji; IGAWA, Yasuhiko; TAKEDA, Masayuki; NISHIZAWA, Osamu; IKEDA, Yasushi; OHKAWA, Sumito Journal: LUTS Issue: Volume 7:Issue 2(2015) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimum Dose of Once‐Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double‐Blind Trial Versus Placebo. Issue 3 (12th February 2015) Authors: YAMAGUCHI, Osamu; UCHIDA, Eiji; HIGO, Naruhito; MINAMI, Hidenao; KOBAYASHI, Shigeo; SATO, Hiroyuki Journal: LUTS Issue: Volume 8:Issue 3(2016) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase III Study to Assess Long‐Term (52‐Week) Safety and Efficacy of Mirabegron, a β3‐Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder. Issue 1 (7th July 2015) Authors: YAMAGUCHI, Osamu; IKEDA, Yasushi; OHKAWA, Sumito Journal: LUTS Issue: Volume 9:Issue 1(2017) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗